Suppression of thymic lymphomas and increased nonthymic lymphomagenesis in Trp53‐deficient mice lacking inducible nitric oxide synthase gene
- 20 May 2004
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 111 (6) , 819-828
- https://doi.org/10.1002/ijc.20350
Abstract
Trp53‐deficient mice spontaneously develop lymphomas, mainly of thymic origin, although the molecular mechanism remains largely unknown. As several interaction effects between p53 and iNOS have been reported, we hypothesized that iNOS activity in the thymus is causally linked to lymphomagenesis in Trp53‐deficient mice. We therefore created mouse strains with different combinations of the Trp53 and iNOS genes. Western blot and histologic analyses showed that the iNOS protein was constitutively expressed in the thymus independently of Trp53 status and its expression was enhanced in Trp53+/– and Trp53–/– mice compared to Trp53+/+ mice. Homozygous disruption of iNOS decreased the incidence of thymic lymphomas by almost 40% (p = 0.087) and 90% (p < 0.05) in Trp53–/– and Trp53+/– mice, respectively, compared to the respective iNOS wild‐type mice but significantly (p < 0.05) increased the development of nonthymic lymphomas in Trp53–/– and Trp53+/– mice. Although iNOS gene disruption did not affect the phenotype of thymic lymphomas, absence of the iNOS gene shifted the spectrum of nonthymic lymphoma from the B‐cell to the T‐cell lineage. RT‐PCR analysis revealed enhanced expression of IL‐10, which could have a promoting effect on lymphomagenesis, even without any stimulation, in the spleen of aging mice with the gene combinations Trp53–/–iNOS–/– and Trp53+/–iNOS–/– but not Trp53–/–iNOS+/+ or Trp53+/–iNOS+/+. These results suggest that iNOS could increase the development of thymic lymphomas in Trp53‐deficient mice. While iNOS may have protective effects against nonthymic lymphomagenesis, the regulation of cytokine production by iNOS may be involved in the underlying mechanism of antilymphomagenesis effects in the peripheral lymphoid organ.Keywords
This publication has 44 references indexed in Scilit:
- The role of nitric oxide in cancerCell Research, 2002
- Bethesda proposals for classification of lymphoid neoplasms in miceBlood, 2002
- Cytokine Profile and Immunomodulation in Asymptomatic Human T-Lymphotropic Virus Type 1–Infected Blood DonorsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Effect of Intragastric Application ofN-Methylnitrosourea inp53 Knockout MiceMolecular Carcinogenesis, 2000
- Nitric oxide‐mediated immunosuppression following murine Echinococcus multilocularis infectionImmunology, 1999
- Serum Soluble CD23 but Not IL8, IL10, GM-CSF, or IFN-γ Is Elevated in Patients with Hepatitis C InfectionClinical Immunology and Immunopathology, 1997
- Interferon-γ-Dependent Expression of Inducible Nitric Oxide Synthase, Interleukin-12, and Interferon-γ-Inducing Factor in Macrophages Elicited by Allografted Tumor CellsBiochemical and Biophysical Research Communications, 1996
- Longevity, Body Weight, and Neoplasia in Ad Libitum-Fed and Diet-Restricted C57BL6 Mice Fed NIH-31 Open Formula DietToxicologic Pathology, 1995
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992
- The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80. Relationship between macrophages, Langerhans cells, reticular cells, and dendritic cells in lymphoid and hematopoietic organs.The Journal of Experimental Medicine, 1983